BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25406006)

  • 1. Cone snail venomics: from novel biology to novel therapeutics.
    Prashanth JR; Brust A; Jin AH; Alewood PF; Dutertre S; Lewis RJ
    Future Med Chem; 2014 Oct; 6(15):1659-75. PubMed ID: 25406006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards an integrated venomics approach for accelerated conopeptide discovery.
    Prashanth JR; Lewis RJ; Dutertre S
    Toxicon; 2012 Sep; 60(4):470-7. PubMed ID: 22564717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale discovery of conopeptides and conoproteins in the injectable venom of a fish-hunting cone snail using a combined proteomic and transcriptomic approach.
    Violette A; Biass D; Dutertre S; Koua D; Piquemal D; Pierrat F; Stöcklin R; Favreau P
    J Proteomics; 2012 Sep; 75(17):5215-25. PubMed ID: 22705119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venomics-Accelerated Cone Snail Venom Peptide Discovery.
    Himaya SWA; Lewis RJ
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29522462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Messy' Processing of χ-conotoxin MrIA Generates Homologues with Reduced hNET Potency.
    Ziegman R; Brust A; Jha P; Cardoso FC; Lewis RJ; Alewood PF
    Mar Drugs; 2019 Mar; 17(3):. PubMed ID: 30875751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conus venom peptide pharmacology.
    Lewis RJ; Dutertre S; Vetter I; Christie MJ
    Pharmacol Rev; 2012 Apr; 64(2):259-98. PubMed ID: 22407615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of the cysteine-rich conotoxin MrIA by using a 1,2,3-triazole as a disulfide bond mimetic.
    Gori A; Wang CI; Harvey PJ; Rosengren KJ; Bhola RF; Gelmi ML; Longhi R; Christie MJ; Lewis RJ; Alewood PF; Brust A
    Angew Chem Int Ed Engl; 2015 Jan; 54(4):1361-4. PubMed ID: 25483297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the peptidome of the South African cone snails Conus pictus and Conus natalis.
    Peigneur S; Van Der Haegen A; Möller C; Waelkens E; Diego-García E; Marí F; Naudé R; Tytgat J
    Peptides; 2013 Mar; 41():8-16. PubMed ID: 22776330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conopeptide characterization and classifications: an analysis using ConoServer.
    Kaas Q; Westermann JC; Craik DJ
    Toxicon; 2010 Jul; 55(8):1491-509. PubMed ID: 20211197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.
    Brust A; Palant E; Croker DE; Colless B; Drinkwater R; Patterson B; Schroeder CI; Wilson D; Nielsen CK; Smith MT; Alewood D; Alewood PF; Lewis RJ
    J Med Chem; 2009 Nov; 52(22):6991-7002. PubMed ID: 19860431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemistry of conotoxins from cone snails].
    Sato K
    Seikagaku; 1999 Mar; 71(3):183-92. PubMed ID: 10332220
    [No Abstract]   [Full Text] [Related]  

  • 12. Drugs from the peptide venoms of marine cone shells.
    Lewis RJ; Bingham JP; Jones A; Alewood PF; Andrews PR
    Australas Biotechnol; 1994; 4(5):298-300. PubMed ID: 7765678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain therapeutics from cone snail venoms: From Ziconotide to novel non-opioid pathways.
    Safavi-Hemami H; Brogan SE; Olivera BM
    J Proteomics; 2019 Jan; 190():12-20. PubMed ID: 29777871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical and functional identification and characterization of novel sulfated alpha-conotoxins from the cone snail Conus anemone.
    Loughnan ML; Nicke A; Jones A; Adams DJ; Alewood PF; Lewis RJ
    J Med Chem; 2004 Feb; 47(5):1234-41. PubMed ID: 14971903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of three novel Gla-containing Conus marmoreus venom peptides, one with a novel cysteine pattern.
    Hansson K; Furie B; Furie BC; Stenflo J
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1081-7. PubMed ID: 15194478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure of chi-conopeptide MrIA, a modulator of the human norepinephrine transporter.
    Nilsson KP; Lovelace ES; Caesar CE; Tynngård N; Alewood PF; Johansson HM; Sharpe IA; Lewis RJ; Daly NL; Craik DJ
    Biopolymers; 2005; 80(6):815-23. PubMed ID: 15931669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The snail companies. Neurex Corporation & Cognetix Inc.
    Wells WA
    Chem Biol; 1998 Sep; 5(9):R235-6. PubMed ID: 9755372
    [No Abstract]   [Full Text] [Related]  

  • 18. From Mollusks to Medicine: A Venomics Approach for the Discovery and Characterization of Therapeutics from Terebridae Peptide Toxins.
    Verdes A; Anand P; Gorson J; Jannetti S; Kelly P; Leffler A; Simpson D; Ramrattan G; Holford M
    Toxins (Basel); 2016 Apr; 8(4):117. PubMed ID: 27104567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium binding properties of synthetic gamma-carboxyglutamic acid-containing marine cone snail "sleeper" peptides, conantokin-G and conantokin-T.
    Prorok M; Warder SE; Blandl T; Castellino FJ
    Biochemistry; 1996 Dec; 35(51):16528-34. PubMed ID: 8987986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stenotrophomonas-Like Bacteria Are Widespread Symbionts in Cone Snail Venom Ducts.
    Torres JP; Tianero MD; Robes JMD; Kwan JC; Biggs JS; Concepcion GP; Olivera BM; Haygood MG; Schmidt EW
    Appl Environ Microbiol; 2017 Dec; 83(23):. PubMed ID: 28986377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.